[go: up one dir, main page]

DK1455770T3 - Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser - Google Patents

Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser

Info

Publication number
DK1455770T3
DK1455770T3 DK02784195T DK02784195T DK1455770T3 DK 1455770 T3 DK1455770 T3 DK 1455770T3 DK 02784195 T DK02784195 T DK 02784195T DK 02784195 T DK02784195 T DK 02784195T DK 1455770 T3 DK1455770 T3 DK 1455770T3
Authority
DK
Denmark
Prior art keywords
treatment
tic disorders
uptake inhibitors
norepinephrine uptake
norepinephrine
Prior art date
Application number
DK02784195T
Other languages
Danish (da)
English (en)
Inventor
Albert John Allen
David Michelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1455770T3 publication Critical patent/DK1455770T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02784195T 2001-11-30 2002-11-12 Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser DK1455770T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33449401P 2001-11-30 2001-11-30
PCT/US2002/033628 WO2003047560A1 (fr) 2001-11-30 2002-11-12 Utilisation d'inhibiteurs de recaptage de norepinephrine dans le traitement de tics

Publications (1)

Publication Number Publication Date
DK1455770T3 true DK1455770T3 (da) 2007-10-08

Family

ID=23307469

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02784195T DK1455770T3 (da) 2001-11-30 2002-11-12 Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser

Country Status (12)

Country Link
US (2) US20050014843A1 (fr)
EP (1) EP1455770B1 (fr)
JP (1) JP2005515199A (fr)
KR (1) KR20050044604A (fr)
AT (1) ATE365035T1 (fr)
AU (1) AU2002347984A1 (fr)
CA (1) CA2466649A1 (fr)
DE (1) DE60220825T2 (fr)
DK (1) DK1455770T3 (fr)
ES (1) ES2287338T3 (fr)
PT (1) PT1455770E (fr)
WO (1) WO2003047560A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
JP2005522445A (ja) * 2002-02-12 2005-07-28 サイプレス バイオサイエンス， インコーポレイテッド 注意欠陥過活動性障害（ａｄ／ｈｄ）の処置方法
KR20060121178A (ko) * 2003-12-12 2006-11-28 일라이 릴리 앤드 캄파니 일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제
EP1842556A4 (fr) * 2005-01-18 2008-12-17 Mitsubishi Tanabe Pharma Corp Agent therapeutique pour le traitement du trouble de l'hyperactivite avec deficit d'attention
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US20080031932A1 (en) * 2006-08-04 2008-02-07 Watson Laboratories, Inc. Transdermal atomoxetine formulations and associated methods
KR102096165B1 (ko) 2018-05-03 2020-04-01 노충구 틱 장애 개선 및 치료 효과를 가지는 약학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
US6323242B1 (en) * 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
JP2003503450A (ja) * 1999-07-01 2003-01-28 ファルマシア・アンド・アップジョン・カンパニー 高選択的ノルエピネフリン再取込みインヒビターおよびその使用方法
CN1396829A (zh) * 2000-02-24 2003-02-12 法玛西雅厄普约翰美国公司 新的药物联合形式
MXPA03006003A (es) * 2001-01-02 2005-09-08 Upjohn Co Nuevas combinaciones de farmacos.

Also Published As

Publication number Publication date
US20080200555A1 (en) 2008-08-21
CA2466649A1 (fr) 2003-06-12
DE60220825D1 (de) 2007-08-02
DE60220825T2 (de) 2008-03-06
EP1455770A1 (fr) 2004-09-15
WO2003047560A1 (fr) 2003-06-12
ATE365035T1 (de) 2007-07-15
EP1455770B1 (fr) 2007-06-20
ES2287338T3 (es) 2007-12-16
US20050014843A1 (en) 2005-01-20
JP2005515199A (ja) 2005-05-26
AU2002347984A1 (en) 2003-06-17
PT1455770E (pt) 2007-09-06
KR20050044604A (ko) 2005-05-12

Similar Documents

Publication Publication Date Title
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
BR0312785A (pt) Tratamento de desordens relacionadas a tnf(alfa)
DK1420801T3 (da) Anvendelse af fucaner til behandling af adhæsioner, arthritis og psoreasis
DK1809280T3 (da) Mitotiske kinesininhibitorer og fremgangsmåder til anvendelse deraf
NO20061092L (no) Heteroarvlaminosulfonvlfenvl-derivater for anvendelse som natrium- eller kalslumkanalblokkere i behandlingen av smerte
EA200602241A1 (ru) Замещённые индазолы, композиции, содержащие указанные индазолы, способ их получения и применение
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
BG108181A (bg) Нови спиротрициклични производни и тяхното използване като инхибитори на фосфодиестераза-7
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
DK1456380T3 (da) SMAD7-inhibitorer til behandling af CNS-sygdomme
DE60108857D1 (de) Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren
DK1315506T3 (da) Phospholipidderivater af valproinsyre og blandinger deraf
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
NO20054371L (no) Somatostatin-dopamin kimaere analoger
ATE399557T1 (de) Selektive norepinephrin-wiederaufnahmehemmer zur behandlung von hitzewallungen
NO20025405D0 (no) Modulatorer for TNF-alfa-signalisering
ATE443044T1 (de) Tace inhibitoren
MY136367A (en) Treatment of cognitive failure
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
EA200200948A1 (ru) Лечение псориаза
BR0115301A (pt) Uso de um inibidor seletivo da recaptação de norepinefrina
DK1438034T3 (da) Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen